SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs > CYTODYN INC (CYDY)

My impression at the time and still is

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
gestalt2 Member Profile
 
Followed By 5
Posts 523
Boards Moderated 1
Alias Born 04/13/16
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 11/16/2017 4:12:12 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/8/2017 4:34:16 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/8/2017 4:34:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/2/2017 4:33:11 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/13/2017 7:20:39 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/11/2017 7:53:23 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/11/2017 7:46:31 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 10/10/2017 9:05:18 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/5/2017 2:56:11 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 10/2/2017 10:00:24 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 9/20/2017 5:10:21 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/8/2017 7:49:58 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/8/2017 7:45:54 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/6/2017 7:01:46 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/25/2017 7:32:05 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/21/2017 4:06:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/9/2017 4:05:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/31/2017 5:41:30 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/31/2017 5:04:43 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/28/2017 4:09:10 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 7/27/2017 5:24:15 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 7/24/2017 7:42:19 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 7/20/2017 6:05:42 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/14/2017 4:09:06 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 7/10/2017 5:29:50 PM
gestalt2   Thursday, 11/09/17 12:05:56 PM
Re: BlackDoggie post# 18071
Post # of 18226 
My impression at the time and still is that because the timelines overlap so closely is that the extra 10 patients are not to difficult to get. The process of pulling together the data I would think is easy to predict. My guess is that the relaxed criteria allowed patients that did not qualify before, now can so it is not hard to get the trial enrolled at 50. The mood about the extra 10 patients in the CC did not seem to me to be presented as a disaster, and might actually be good because the data may be much more representative of the HIV market.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist